Amrize Ltd
NYSE:AMRZConstruction Materials
+$1.05 today
- Market cap
- $22.10B
- Beta
- -0.09
Volume 3.68M
Average 3.11M
AMRZ Total Non-current Liabilities
All obligations due after more than one year.
Amrize LtdNYSE: AMRZ
Total Non-current Liabilities · Q2 FY2026 · quarter ended Jun 2026
Total non-current liabilities falls 7.5% from a year ago
Total non-current liabilities stood at $7.59B at the end of Q2 FY2026, down 7.5% from a year earlier and down 6.6% from the prior quarter. Over 3 fiscal years it compounded at -7.3% a year.
Context
- Total non-current liabilities amounted to 30.9% of total assets at the end of Q2 FY2026, down 3.7 pp from a year earlier.
- Total non-current liabilities increased in 2 of the last 3 fiscal years.
What to watch
Whether total non-current liabilities keeps falling in the next quarterly balance sheet after a -7.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Non-current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 8.14B USD
- Year-over-year change
- +4.6%
- 3-year CAGR
- -7.3%
| Period | Period end | Total Non-current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 8.14B | +4.6% |
| FY2024 | 2024-12-31 | 7.78B | -31.8% |
| FY2023 | 2023-12-31 | 11.4B | +11.7% |
| FY2022 | 2022-12-31 | 10.21B | — |
Total Non-current Liabilities vs competitors
How AMRZ compares with its peers on the latest reported figures
- AMRZ's Jun 2026 total non-current liabilities of $7.59B is the 3rd highest of the 7 companies compared; the peer median is $6.34B.
- Its year-over-year change of -7.5% is the 6th highest of 7, against a peer median of +5.3%.
- Total non-current liabilities amounts to 30.9% of total assets for AMRZ, versus a peer median of 43.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $23.04B | +6.3% | +20.0% | 39.3% | |
| Jun 2026 | $8.02B | +4.3% | +6.9% | 37.6% | |
AMRZAmrize Ltd | Jun 2026 | $7.59B | -7.5% | -7.3% | 30.9% |
| Jun 2026 | $6.72B | -6.7% | +4.4% | 40.9% | |
| Jun 2026 | $5.95B | -11.2% | +16.9% | 46.8% | |
| Jun 2026 | $3.73B | +38.2% | +6.2% | 59.9% | |
| Jun 2026 | $2.13B | +30.3% | +15.1% | 54.6% | |
| Peer median (excluding AMRZ) | $6.34B | +5.3% | +11.0% | 43.8% | |
Competitors are the stored peer set for AMRZ. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Amrize Ltd
NYSE:AMRZ
Intrinsic Alpha fair value
Locked
Current Price
$40.41
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.